Previous 10 | Next 10 |
Lucira Health, Inc. (LHDX) Q4 2021 Earnings Conference Call March 10, 2022, 04:30 PM ET Company Participants Greg Chodaczek - Gilmartin Group, IR Erik Engelson - President, CEO Dan George - CFO Conference Call Participants Derik De Bruin - Bank of America Merrill Lynch Griffin Soriano - Willi...
Image source: The Motley Fool. Lucira Health, Inc. (NASDAQ: LHDX) Q4 2021 Earnings Call Mar 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Lucira Health, Inc. (LHDX) Q4 2021 Earnings Call Transcript
Lucira Health press release (NASDAQ:LHDX): Q4 GAAP EPS of -$0.20 beats by $0.29. Revenue of $61.12M (+23407.7% Y/Y) beats by $14.22M. For further details see: Lucira Health GAAP EPS of -$0.20 beats by $0.29, revenue of $61.12M beats by $14.22M
EMERYVILLE, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company focused on the development and commercialization of transformative and innovative in...
Lucira Health went public in February 2021, raising $153 million in an IPO. The firm is developing various infectious disease testing kits. Its first kit, for COVID-19, has produced rapidly growing revenue since launch. LHDX is still seeking to diversify its revenue streams, s...
EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, to...
EMERYVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on Februa...
Lucira™ Health Commits 2 Million At-Home Molecular COVID-19 Test Kits on Amazon Lucira Health's rapid accurate molecular at-home test is available for purchase nationwide with fast, free delivery through Amazon Prime PR Newswire EMERYVILLE, Calif. , Feb....
Lucira's COVID-19 test is the only EUA authorized rapid at-home self-test that delivers PCR accuracy and early detectability in a single-use test kit with results in 30 minutes Availability in the Optum Store expands access to this unique testing option amidst a surge of US ...
EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced preliminary revenue results for t...
News, Short Squeeze, Breakout and More Instantly...
Lucira Health Inc. Company Name:
LHDX Stock Symbol:
NASDAQ Market:
Why Liquidity and Volume Are Important for Trading Penny Stocks Penny stocks are a popular investment choice for traders due to their low price and potential for high returns. However, trading penny stocks can be risky, especially if the trader is not well-informed about the market. In th...